Mapping the domains of the interaction of the vitamin D receptor and steroid receptor coactivator-1

Molecular Endocrinology

Volumn 12, Issue 1, 1998, Pages 57-65

  Gill, Rajbir K ^a,b   Atkins, Loretta M ^a   Hollis, Bruce W ^a   Bell, Norman H ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b RALPH H JOHNSON VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; STEROID RECEPTOR; VITAMIN D RECEPTOR;

ARTICLE; BINDING AFFINITY; DELETION MUTANT; DNA BINDING; ENZYME ACTIVITY; GENE MAPPING; HUMAN; HUMAN TISSUE; LIGAND BINDING; MUTATION RATE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; RECEPTOR AFFINITY; TANDEM REPEAT;

AMINO ACID SEQUENCE; BETA-GALACTOSIDASE; CALCITRIOL; DNA, COMPLEMENTARY; GENE EXPRESSION REGULATION; GENE LIBRARY; HISTONE ACETYLTRANSFERASES; HUMANS; KIDNEY; LIGANDS; MOLECULAR SEQUENCE DATA; PEPTIDE MAPPING; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, CALCITRIOL; RECEPTORS, STEROID; RECOMBINANT FUSION PROTEINS; SACCHAROMYCES CEREVISIAE; TRANSCRIPTION FACTORS;

EID: 0031893307     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.12.1.57     Document Type: Article

References (61)

1. Evans RM 1988 The steroid and thyroid hormone receptor superfamily. Science 240:889-895
2. De Luca LM 1991 Retinoids and their receptors in differentiation, embryo-genesis, and neoplasia. FASEB J 5:2924-2933
3. Glass CK, Holloway JM 1990 Regulation of gene expression by the thyroid hormone receptor. Biochim Biophys Acta 1032:157-176
4. Yu VC, Näär AM, Rosenfield MG 1992 Transcriptional regulation by the nuclear receptor superfamily. Curr Opin Biotechnol 3:597-602
5. 3 receptors. Cell 65:1255-1266
6. 3. Proc Natl Acad Sci USA 87:369-373
7. Markose ER, Stein JL, Stein GS, Lian JB 1990 Vitamin D-mediated modifications in protein-DNA interactions at two promoter elements of the osteocalcin gene. Proc Natl Acad Sci USA 87:1701-1705
8. Terpening CM, Haussler CA, Jurutka PW, Galligan MA, Komm BS, Haussler MR 1991 Vitamin D-mediated modifications in protein-DNA interactions at two promoter elements of the osteocalcin gene. Mol Endocrinol 5:73-385
9. Ozono K, Liao J, Kerner SA, Pike JW 1990 The vitamin D-responsive element in the human osteocalcin gene: association with a nuclear proto-oncogene enhancer. J Biol Chem 265:21881-21888
10. 3 enhancement of mouse secreted phosphoprotein 1 (SPP-1 or osteopontin) gene expression. Proc Natl Acad Sci USA 87: 9995-9999
11. 3 24-hydroxylase gene. J Biol Chem 269:10545-10550
12. 3. J Biol Chem 268:27371-27380
13. 3- and butyrate-inducible responses. Proc Natl Acad Sci USA 90:2984-2988
14. Candeliere GA, Jurutka PW, Haussler MR, St-Arnaud R 1996 A composite element binding the vitamin D receptor, retinoid X receptor alpha, and a member of the CTF/NF-1 family of transcription factors mediates the vitamin D responsiveness of the c-fos promoter. Mol Cell Biol 16:584-592
15. Sone T, Ozono K, Pike JW 1991 A 55-kilodalton accessory factor facilitates vitamin D receptor DNA binding. Mol Endocrinol 5:1578-1586
16. 3-modulated hetero-dimer. J Biol Chem 266:23296-23305
17. 3. Proc Natl Acad Sci USA 87:9751-9755
18. MacDonald PN, Haussler CA, Terpening CM, Galligan MA, Reeder MC, Whitfield GK, Haussler MR 1991 Baculovirus-mediated expression of the human vitamin D receptor. Functional characterization, vitamin D response element interactions, and evidence for a receptor auxiliary factor. J Biol Chem 266:18808-18813
19. Yu VC, Delsert C, Andersen B, Holloway JM, Devary OV, Näär AM, Kim SY, Boutin JM, Glass CK, Rosenfield MG 1991 RXR beta: a coregulator that enhances binding of retinoic acid, thyroid hormone, and vitamin D receptors to their cognate response elements. Cell 67:1251-1266
20. Kliewer SA, Umesono K, Mangelsdorf DJ, Evans RM 1992 Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors. Nature 355:446-449
21. 3-activated expression of the rat osteocalcin gene. Mol Cell Biol 13:5907-5917
22. Nakajima S, Hsieh JC, MacDonald PN, Galligan MA, Haussler CA, Whitfield CK, Haussler MR 1994 The C-terminal region of the vitamin D receptor is essential to form a complex with a receptor auxiliary factor required for high affinity binding to the vitamin D-responsive element. Mol Endocrinol 8:159-172
23. Kephart DD, Walfish PG, DeLuca HF, Butt TR 1996 Retinoid X receptor isotype identity directs human vitamin D receptor heterodimer transactivation from the 24-hydroxylase vitamin D response elements in yeast. Mol Endocrinol 10:408-419
24. Jin CH, Pike JW 1996 Human vitamin D receptor-dependent transactivation in Saccharomyces cerevisiae requires retinoid X receptor. Mol Endocrinol 10:196-205
25. Oñate SA, Tsai SY, Tsai MJ, O'Malley BW 1995 Sequence and characterization of a coactivator for the steroid hormone receptor superfamily. Science 270: 1354-1357
26. Takeshita A, Yen PM, Misiti S, Cardona GR, Liu Y, Chin WW 1996 Molecular cloning and properties of a full-length putative thyroid hormone receptor coactivator. Endocrinology 137:3594-3597
27. Mitchell PJ, Tjian R 1989 Transcriptional regulation in mammalian cells by sequence-specific DNA binding proteins. Science 245:371-378
28. Ptashne M 1988 How eukaryotic transcriptional activators work. Nature 335:683-689
29. Tjian R, Maniatis T 1994 Transcriptional activation: a complex puzzle with few easy pieces. Cell 77:5-8
30. MacDonald PN, Sherman DR, Dowd DR, Jefcoat SC, DeLisle RK 1995 The vitamin D receptor interacts with general transcription factor IIB. J Biol Chem 270: 4748-4752
31. Blanco JCG, Wang IM, Tsai SY, Tsai MJ, O'Malley BW, Jurutka PW, Haussler MR, Ozato K 1995 Transcription factor TFIIB and the vitamin D receptor cooperatively activate ligand-dependent transcription. Proc Natl Acad Sci USA 92:1535-1539
32. Le Douarin B, Zechel C, Gamier JM, Lutz Y, Tora L, Pierrat B, Heery D, Gronemeyer H, Chambon P, Losson R 1995 The N-terminal part of TIF1, a putative mediator of the ligand-dependent activation function (AF-2) of nuclear receptors, is fused to B-raf in the oncogenic protein T18. EMBO J 14:2020-2033
33. Lee JW, Ryan F, Swaffled JC, Johnston SA, Moore DD 1995 Interaction of thyroid-hormone receptor with a conserved transcriptional mediator. Nature 374:91-94
34. Lee JW, Choi HS, Gyuris J, Brent R, Moore DD 1995 Two classes of proteins dependent on either the presence or absence of thyroid hormone for interaction with the thyroid hormone receptor. Mol Endocrinol 9:243-254
35. Cavailles V, Dauvois S, Danielian PS, Parker MG 1994 Interaction of proteins with transcriptionally active estrogen receptors. Proc Natl Acad Sci USA 91:10009-10013
36. Cavailles V, Dauvois S, L'Horset F, Lopez G, Hoare S, Kushner PJ, Parker MG 1995 Nuclear factor RIP140 modulates transcriptional activation by the estrogen receptor. EMBO J 14:3741-3751
37. Hong H, Kohli K, Trivedi A, Johnson DL, Stallcup MR 1996 GRIP1, a novel mouse protein that serves as a transcriptional coactivator in yeast for the hormone binding domains of steroid receptors. Proc Natl Acad Sci USA 93:4948-4952
38. Hörlein AJ, Näär AM, Heinzel T, Torchia J, Gloss B, Kurokawa R, Ryan A, Kamei Y, Söderström M, Glass C, Rosenfield MG 1995 Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor. Nature 377:397-404
39. Chen JD, Evans RM 1995 A transcriptional co-repressor that interacts with nuclear hormone receptors. Nature 377:454-457
40. Nakajima S, Hsieh JC, MacDonald PN, Galligan MA, Haussler CA, Whitfield CK, Haussler MR 1994 The C-terminal region of the vitamin D receptor is essential to form a complex with a receptor auxiliary factor required for high affinity binding to the vitamin D-responsive element. Mol Endocrinol 8:159-172
41. 3 receptor regulate osteocalcin gene expression. Mol Endocrinol 3:635-644
42. Barettino D, Vivanco Ruiz MM, Stunnenberg HG 1994 Characterization of the ligand-dependent transactivation domain of thyroid hormone receptor. EMBO J 13:3039-3049
43. Durand B, Saunders M, Gaudon C, Roy B, Losson R, Chambon P 1994 Activation function 2 (AF-2) of retinoic acid receptor and 9-cis retinoic acid receptor: presence of a conserved autonomous constitutive activating domain and influence of the nature of the response element on AF-2 activity. EMBO J 13:5370-5382
44. Danielian PS, White R, Lees JA, Parker MG 1992 Identification of a conserved region required for hormone dependent transcriptional activation by steroid hormone receptors. EMBO J 11:1025-1033
45. Zenke M, Munoz A, Sap J, Vennoström B, Beug H 1990 v-erbA oncogene activation entails the loss of hormone-dependent regulator activity of c-erbA. Cell 61: 1035-1049
46. Saatcioglu F, Bartunek P, Deng T, Zenke M, Karin M 1993 A conserved C-terminal sequence that is deleted in v-ErbA is essential for the biological activities of c-ErbA (the thyroid hormone receptor). Mol Cell Biol 13:3675-3685
47. Giniger E, Ptashne M 1987 Transcription in yeast activated by a putative amphipathic alpha helix linked to a DNA binding unit. Nature 330:670-672
48. Bourguet W, Ruff M, Chambon P, Gronemeyer H, Moras D 1995 Crystal structure of the ligand-binding domain of the human nuclear receptor RXR-alpha. Nature 375:377-382
49. Wagner RL, Apriletti JW, McGrath ME, West BL, Baxter JD, Fletterick RJ 1995 A structural role for hormone in the thyroid hormone receptor. Nature 378:690-397
50. Renaud JP, Rochel N, Chambon P, Gronemeyer H, Moras D 1995 Crystal structure of the RAR-gamma ligand-binding domain bound to all-trans retinoic acid. Nature 378:681-689
51. Henttu PM, Kalkhoven E, Parker MG 1997 AF-2 activity and recruitment of steroid receptor coactivator 1 to the estrogen receptor depend on a lysine residue conserved in nuclear receptors. Mol Cell Biol 17:1832-1839
52. Schulman IG, Juguilon H, Evans RM 1996 Activation and repression by nuclear hormone receptors: hormone modulates an equilibrium between active and repressive states. Mol Cell Biol 16:3807-3813
53. McInerney EM, Ince BA, Shapiro DJ, Katzenellenbogen BS 1996 A transcriptionally active estrogen receptor mutant is a novel type of dominant negative inhibitor of estrogen action. Mol Endocrinol 10:1519-1526
54. Chien CT, Bartel PL, Stemglanz R, Field S 1991 The two-hybrid system: a method to identify and clone genes for proteins that interact with a protein of interest. Proc Natl Acad Sci USA 88:9578-9582
55. Baker AR, McDonnell DP, Hughes M, Crisp TM, Mangelsdorf DJ, Haussler MR, Pike JW, Shine J, O'Malley 1988 Cloning and expression of full-length cDNA encoding human vitamin D receptor. Proc Natl Acad Sci USA 85:3294-3298
56. Field S, Song O 1989 A novel genetic system to detect protein-protein interactions. Nature 340:245-246
57. Bartel PL, Chein CT, Sternglanz R, Fields S 1995 Using the two-hybrid system to detect protein-protein interactions. In: Hartley DA (ed) Cellular Interactions in Development: A Practical Approach. Oxford University Press, Oxford, pp 153-179
58. Ward AC, Castelli LA, Macreadie IG, Azad AA 1994 Vectors for Cu(2+)-inducible production of glutathione S-transferase-fusion proteins for single-step purification from yeast. Yeast 10:441-449
59. Bradford MM 1976 A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254
60. 3-receptor complexes. Anal Biochem 92:314-323
61. De León DD, Asmerom Y 1997 Quantification of insulin-like growth factor I (IGF-I) without interference by IGF binding proteins. Endocrinology 138:2199-2202